Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

A genetics-led approach defines the drug target landscape of 30 immune-related traits

Journal article

Fang H. et al, (2019), Nature Genetics

TNF RECEPTOR 2 PLAYS AN IMMUNOREGULATORY AND ANTI-INFLAMMATORY ROLE IN ARTHRITIS

Conference paper

Tseng W-Y. et al, (2018), ANNALS OF THE RHEUMATIC DISEASES, 77, 250 - 251

Target Identification Using Chemical Probes.

Chapter

Moustakim M. et al, (2018), 610, 27 - 58

TNFR signalling and its clinical implications

Journal article

Tseng WY. et al, (2018), Cytokine, 101, 19 - 25

Natural killer (NK) cells and gamma delta T cells differentially modulate Th17-driven disease in ankylosing spondylitis

Conference paper

Wythe S. et al, (2016), EUROPEAN JOURNAL OF IMMUNOLOGY, 46, 67 - 67

Investigating the Role of Toll-Like Receptors in Models of Arthritis.

Chapter

Piccinini AM. et al, (2016), 1390, 351 - 381

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production.

Journal article

Blazek K. et al, (2015), J Exp Med, 212, 845 - 853

OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis.

Journal article

Gwyer Findlay E. et al, (2014), Proc Natl Acad Sci U S A, 111, 2289 - 2294

Nuclear Receptor 4A2 Is Differentially Expressed In Animal Models Of RA During Inflammation and Resolution

Conference paper

Everett J. et al, (2013), ARTHRITIS AND RHEUMATISM, 65, S542 - S542

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.

Journal article

Palfreeman AC. et al, (2013), Drug Des Devel Ther, 7, 201 - 210

Load More